Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy

doi:10.3748/wjg.v19.i47.8867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5765)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

373

HTML

3219

Figures (1-1)

287

Tables (1-1)

249

Sum=4128

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

791

Download

846

Sum=1637

Dec 21, 2013 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 21, 2013; 19(47): 8867-8872
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8867

Open in New Tab Full Size Figure Download Figure

Figure 1 Representative scheme of the hepatitis B virus genome. Hepatitis B virus (HBV) genome consists of partially double-stranded DNA with four overlapping open reading frames. ORF: Open reading frame; DR: Direct repeat.

Citation: Song IH, Kim SM, Choo YK. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. World J Gastroenterol 2013; 19(47): 8867-8872
URL: https://www.wjgnet.com/1007-9327/full/v19/i47/8867.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i47.8867